Inactive Instrument

Other languages Concert Pharmaceuticals, Inc.

Equities

CNCE

US2060221056

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Concert Pharmaceuticals Announces the Presentation of Data from its Phase 3 Clinical Trial, THRIVE-AA2	23-03-18
Sun Pharmaceutical Completes Acquisition of Concert Pharmaceuticals	23-03-06
Sun Pharmaceutical Industries Limited completed the acquisition of Concert Pharmaceuticals, Inc..	23-03-05
Concert Pharmaceuticals Says Deuruxolitinib Maintains FDA Breakthrough Therapy Designation to Treat Alopecia Areata	23-02-15
Concert Pharmaceuticals, Inc. Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia Areata	23-02-15
Insider Sell: Concert Pharmaceuticals	23-01-31
Indian shares set for muted start on rate hike concerns	23-01-19
Sun Pharmaceutical to Acquire US-Based Concert Pharmaceuticals in $576 Million Deal	23-01-19
Sector Update: Healthcare Stocks Gain on Thursday	23-01-19
Sector Update: Health Care Stocks Grinding Out Modest Gains	23-01-19
Sector Update: Health Care	23-01-19
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Thursday	23-01-19
Sector Update: Health Care	23-01-19
Concert Pharmaceuticals to Merge with Sun Pharmaceutical; Shares Rise Pre-Bell	23-01-19
India's Sun Pharma to acquire Concert for $8 per share	23-01-19
Concert Pharmaceuticals Announces Presentation of Deuruxolitinib Thrive-Aa1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research	22-11-21
Concert Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07
Concert Pharmaceuticals Announces Presentation of CTP-543 THRIVE-AA1 Phase 3 Data in Alopecia Areata During Late Breaking Session at EADV Congress	22-09-10
Sector Update: Health Care Stocks Decline Premarket Monday	22-08-22
Concert Pharmaceuticals Says BVF Partners, RA Capital Management Exercise Warrants Under Financing Deal	22-08-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Concert Pharmaceuticals, Inc.

Equities

CNCE

US2060221056

Other languages

Filters